Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development

C Dutruel1, F Bergmann2, I Rooman3

  • 1Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Oncogene
|August 6, 2013
PubMed

Insights

Epigenetic silencing of the WNK2 gene through hypermethylation is an early event in pancreatic cancer development. This downregulation promotes tumor growth by affecting the ERK-MAPK pathway.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with poorly understood epigenetic mechanisms.
  • Genetic alterations are well-studied, but the role of epigenetic silencing in PDAC pathogenesis remains unclear.

Purpose of the Study:

  • To investigate the contribution of epigenetically silenced genes to PDAC development.
  • To identify specific genes downregulated early in PDAC due to epigenetic alterations.

Main Methods:

  • Analysis of highly methylated DNA from PDAC, chronic pancreatitis (CP), and normal tissues using CpG island microarrays.
  • Investigation of WNK2 in tissue microarrays, methylation analysis of pancreatic intraepithelial neoplasia (PanIN), and PDAC mouse models.
  • Re-expression studies after demethylation and cell growth assays with WNK2 overexpression.

Main Results:

  • WNK2 was identified as a tumor suppressor gene downregulated early in PDAC development.
  • WNK2 hypermethylation was observed in PDAC, CP, PanIN lesions, and a PDAC mouse model.
  • WNK2 downregulation correlated with reduced cell growth and negatively with pERK1/2 expression, suggesting involvement in the ERK-MAPK pathway.

Conclusions:

  • WNK2 promoter hypermethylation is an early event in PDAC pathogenesis.
  • Downregulation of WNK2 contributes to tumor cell proliferation, potentially via the ERK-MAPK pathway.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...